ConductScience.org, home

Paper33188564

Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review.

Kennedy M. Drug Test Anal, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review. Papers, record 33188564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33188564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review.
PubMed
Journal
Drug Test Anal
PubMed
Year
2021
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2021-10-07
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kennedy MMichaelhttps://orcid.org/0000-0001-5676-2010

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bronchodilator AgentsMajor topic
ExerciseMajor topic
Performance-Enhancing SubstancesMajor topic
TheobromineMajor topic
TheophyllineMajor topic
Humans
Sports

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42511250Methylxanthine Content in Green Tea Supplements: UHPLC Quantification, Method Validation, and Implications for Ergogenic Dosing in Athletes.Foods2026https://conductscience.org/library/papers/42511250PubMed
41440783Performance-Enhancing Effects of Inhaled Medications: Implications for Heart, Muscle Function, and Doping Detection in Athletes.J Funct Morphol Kinesiol2025https://conductscience.org/library/papers/41440783PubMed
41048238"Brain doping" substances: prohibited or not in sports?Biol Sport2025https://conductscience.org/library/papers/41048238PubMed
40049629Effects of Dimenhydrinate on Motor Behavior and Vascular Function: Possible Implications for the Field of Sports.Drug Test Anal2025https://conductscience.org/library/papers/40049629PubMed
39007997Influence of the CYP1A2 c.-163 A > C polymorphism in the effect of caffeine on fat oxidation during exercise: a pilot randomized, double-blind, crossover, placebo-controlled trial.Eur J Nutr2024https://conductscience.org/library/papers/39007997PubMed
37754829The Relationship between Changes in MYBPC3 Single-Nucleotide Polymorphism-Associated Metabolites and Elite Athletes' Adaptive Cardiac Function.J Cardiovasc Dev Dis2023https://conductscience.org/library/papers/37754829PubMed
36212869Metabolomic and metagenomic analyses of the Chinese mitten crab Eriocheir sinensis after challenge with Metschnikowia bicuspidata.Front Microbiol2022https://conductscience.org/library/papers/36212869PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33188564

GET https://conductscience.org/api/papers/v1/33188564/authors